Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NSE - Delayed Quote INR

Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS.NS)

Compare
47.06
+1.78
+(3.93%)
At close: 3:29:50 PM GMT+5:30
Loading Chart for AAREYDRUGS.NS
  • Previous Close 45.28
  • Open 46.98
  • Bid --
  • Ask --
  • Day's Range 44.59 - 47.54
  • 52 Week Range 32.85 - 74.80
  • Volume 58,276
  • Avg. Volume 32,672
  • Market Cap (intraday) 1.345B
  • Beta (5Y Monthly) 0.63
  • PE Ratio (TTM) 22.30
  • EPS (TTM) 2.11
  • Earnings Date May 28, 2025 - Jun 2, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Aarey Drugs & Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India. The company provides mono methyl and die methyl urea, ortho para nitro anisole, 2 bromomethyl 1, and 3 dioxalane and uracile, as well as active pharma ingredients, such as metformin HCL, mefenamic acid, and doxophylline. It also offers chemicals and solvents, including aromatic chemicals, chemical acids, chlor alkalies, glycols and glycol ethers, fiber intermediates, acetates and esters, and chlorinated solvents, as well as industrial alchols, ketones, amines, oleochemicals, intermediates, olefines, phosphates, fertilizers, monomers, and chemicals. In addition, the company trades in industrial solvents and chemicals.The company's pharmaceutical products are used by pharmaceutical formulation manufacturers and pharmaceutical merchant exporters. Aarey Drugs & Pharmaceuticals Limited was incorporated in 1990 and is headquartered in Mumbai, India.

www.aareydrugs.com

--

Full Time Employees

March 31

Fiscal Year Ends

Recent News: AAREYDRUGS.NS

View More

Performance Overview: AAREYDRUGS.NS

Trailing total returns as of 4/8/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

AAREYDRUGS.NS
17.58%
S&P BSE SENSEX (^BSESN)
5.01%

1-Year Return

AAREYDRUGS.NS
2.87%
S&P BSE SENSEX (^BSESN)
0.69%

3-Year Return

AAREYDRUGS.NS
0.99%
S&P BSE SENSEX (^BSESN)
24.86%

5-Year Return

AAREYDRUGS.NS
7.57%
S&P BSE SENSEX (^BSESN)
148.30%

Compare To: AAREYDRUGS.NS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AAREYDRUGS.NS

View More

Valuation Measures

Annual
As of 4/7/2025
  • Market Cap

    1.29B

  • Enterprise Value

    1.67B

  • Trailing P/E

    21.43

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.22

  • Price/Book (mrq)

    0.95

  • Enterprise Value/Revenue

    0.29

  • Enterprise Value/EBITDA

    12.80

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.99%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    5.76B

  • Net Income Avi to Common (ttm)

    57.06M

  • Diluted EPS (ttm)

    2.11

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    14.9M

  • Total Debt/Equity (mrq)

    28.51%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: AAREYDRUGS.NS

View More

Company Insights: AAREYDRUGS.NS

Research Reports: AAREYDRUGS.NS

View More

People Also Watch